Liposomal NMN 70% — High Purity NAD+ Precursor Supplement

Product Overview

liposomal NMN 70% is a premium-grade, liposomal-encapsulated form of β-nicotinamide mononucleotide (β-NMN), the biologically active isomer that serves as a direct substrate for NAD+ biosynthesis in the salvage pathway. NAD+ (nicotinamide adenine dinucleotide) is a critical redox cofactor and signaling molecule that regulates cellular metabolism, genome stability, and stress responses, with levels declining significantly during aging. By delivering NMN in a phospholipid bilayer delivery system, this product addresses the fundamental limitations of conventional NMN: its structural instability and limited oral bioavailability.

Why Liposomal Technology?

NMN is inherently unstable in aqueous environments and susceptible to degradation into nicotinamide (NAM) under physiological conditions. Conventional oral NMN achieves limited bioavailability due to rapid degradation in the gastrointestinal tract and inefficient cellular uptake.

Liposomal encapsulation provides three critical advantages:

1. Structural Protection — The phospholipid bilayer shields NMN from enzymatic degradation and hydrolysis during digestive transit, preserving its intact molecular structure until reaching target cells.

2. Enhanced Cellular Uptake — liposomes fuse directly with cell membranes, facilitating efficient cytoplasmic delivery of NMN and bypassing passive diffusion limitations. Encapsulation efficiency can be optimized through controlled manufacturing processes.

3. Improved Stability — Liposomal encapsulation significantly enhances NMN stability, preventing its degradation into inactive nicotinamide and maintaining potency throughout shelf life.

Product Specifications